Overview
Martin Schalling practices in Vienna, Austria. Mr. Schalling is rated as an Advanced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). His top areas of expertise are Essential Thrombocythemia, Myelofibrosis, Myeloproliferative Neoplasms (MPN), and Polycythemia Vera.
His clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Essential ThrombocythemiaMr. Schalling isDistinguished. Learn about Essential Thrombocythemia.
- MyelofibrosisMr. Schalling isDistinguished. Learn about Myelofibrosis.
- Advanced
- Blood ClotsMr. Schalling isAdvanced. Learn about Blood Clots.
- Myeloproliferative Neoplasms (MPN)Mr. Schalling isAdvanced. Learn about Myeloproliferative Neoplasms (MPN).
- Polycythemia VeraMr. Schalling isAdvanced. Learn about Polycythemia Vera.
- SplenomegalyMr. Schalling isAdvanced. Learn about Splenomegaly.